All In Biotech

Free tool

FAERS Monitor: Uloric

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021856 or its brand name (Uloric, Febuxostat). Reports on generic versions are filed under their own applications.

Reports

17,000

Serious

12,910

76% of reports

Hospitalization

7,336

Death reported

2,242

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea904
  • acute kidney injury881
  • nausea870
  • rash812
  • off label use772
  • drug ineffective709
  • gout700
  • dyspnoea651
  • fatigue628
  • headache599
  • anaemia598
  • pneumonia569
  • pyrexia565
  • renal impairment541
  • death538

Reports by year received

View as table
YearReports
200973
2010105
2011196
2012226
2013294
2014356
20152,414
2016863
2017867
20181,045
20191,142
20201,165
20211,431
20221,668
20231,474
20241,466
20251,325
2026890

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,159 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
goutSignal70050.246.632,403
renal impairmentSignal5418.07.43,305
acute kidney injurySignal8817.26.74,668
anaemiaSignal5983.93.61,288
rashSignal8122.32.2612
pneumoniaSignal5692.22.0366
pyrexiaSignal5652.01.9295
diarrhoea9041.71.6288
dyspnoea6511.41.384
nausea8701.41.386
headache5991.21.117
off label use7721.11.06
fatigue6281.00.90
death5380.80.737
drug ineffective7090.70.6127

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.